z-logo
open-access-imgOpen Access
Profile of Enfortumab Vedotin in the Treatment of Urothelial Carcinoma: The Evidence to Date
Author(s) -
Mohamad Moussa,
Athanasios Papatsoris,
Mohamed Abou Chakra,
Athanasios Dellis
Publication year - 2021
Publication title -
drug design development and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.964
H-Index - 64
ISSN - 1177-8881
DOI - 10.2147/dddt.s240854
Subject(s) - urothelial cancer , urothelial carcinoma , metastatic urothelial carcinoma , medicine , oncology , anticancer drug , safety profile , cancer , drug , cancer research , adverse effect , bladder cancer , pharmacology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom